{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:12:58Z","timestamp":1788401578011,"version":"build-2803163510"},"reference-count":21,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/21645515.2025.2569735","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T14:04:20Z","timestamp":1760969060000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Safety monitoring of GSK\u2019s quadrivalent seasonal influenza vaccine in European countries during the 2023\/24 flu season: A multicenter, non-interventional study"],"prefix":"10.1080","volume":"21","author":[{"given":"Ignacio","family":"Salamanca de la Cueva","sequence":"first","affiliation":[{"name":"Instituto Hispalense de Pediatr\u00eda","place":["Seville, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Brotons","sequence":"additional","affiliation":[{"name":"Institut Sant Pau","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Maier","sequence":"additional","affiliation":[{"name":"PaedResearch, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Pir\u00e7on","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Gupta","sequence":"additional","affiliation":[{"name":"GSK","place":["Bangalore, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Eckermann","sequence":"additional","affiliation":[{"name":"Studienpraxis Heimeranplatz, M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanja","family":"Nikic","sequence":"additional","affiliation":[{"name":"GSK","place":["Rockville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Martinez Gomez","sequence":"additional","affiliation":[{"name":"Hospital Universitari Vall d\u2019Hebron","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Alsdurf","sequence":"additional","affiliation":[{"name":"GSK","place":["Rockville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"e_1_3_7_2_1","unstructured":"Centers for Disease Control and Prevention. Signs and symptoms of flu. 2024 [accessed 2025 Jan 5]. https:\/\/www.cdc.gov\/flu\/signs-symptoms\/index.html."},{"key":"e_1_3_7_3_1","unstructured":"World Health Organization. Influenza (seasonal). 2025 [accessed 2025 Jan 5]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"e_1_3_7_4_1","unstructured":"European Centre for Disease Prevention and Control. Factsheet about seasonal influenza. 2022 [accessed 2025 Jan 5]. https:\/\/www.ecdc.europa.eu\/en\/seasonal-influenza\/facts\/factsheet."},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.11.080"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.13.04003"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050714"},{"key":"e_1_3_7_8_1","unstructured":"World Health Organization. Influenza. 2025 [accessed 2025 Jan 5]. https:\/\/www.who.int\/teams\/health-product-policy-and-standards\/standards-and-specifications\/norms-and-standards\/vaccine-standardization\/influenza#:~:text=Characteristic%20of%20many%20RNA%20genome in%20HA%20and%20NA%20antigens."},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.02.012"},{"key":"e_1_3_7_10_1","unstructured":"European Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee (PRAC). Interim guidance on enhanced safety surveillance for seasonal influenza vaccines in the EU. EMA\/PRAC\/222346\/2014. 2014 [accessed 2024 Dec 5]. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/interim-guidance-enhanced-safety-surveillance-seasonal-influenza-vaccines-eu_en.pdf."},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.2196\/12016"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1565258"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1705112"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-021-01121-8"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-021-00571-y"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13098"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-024-01456-y"},{"key":"e_1_3_7_18_1","unstructured":"Division of AIDS. National Institute of Allergy and Infectious Diseases. National Institutes of Health. US Department of Health and Human Services. Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events. Corrected version 2.1. 2017 [accessed 2025 Aug 8]. https:\/\/rsc.niaid.nih.gov\/sites\/default\/files\/daidsgradingcorrectedv21.pdf."},{"key":"e_1_3_7_19_1","unstructured":"World Health Organization. Who regional office for Europe recommendations on influenza vaccination for the 2021\/2022 season during the ongoing COVID-19 pandemic. Regional office for Europe. 2021 [accessed 2024 Dec 5]. https:\/\/apps.who.int\/iris\/handle\/10665\/347890."},{"key":"e_1_3_7_20_1","unstructured":"World Health Organization. Who COVID-19: case definitions. Updated in public health surveillance for COVID-19. 2022 Jul 22 [accessed 2024 Dec 6]. https:\/\/iris.who.int\/bitstream\/handle\/10665\/360579\/WHO-2019-nCoV-Surveillance-Case-Definition-2022.1-eng.pdf?sequence=1."},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/26.4.404"},{"key":"e_1_3_7_22_1","unstructured":"GlaxoSmithKline Biologicals. Fluarix Tetra. Quadrivalent influenza vaccine (split virion inactivated). 2021 [accessed 2024 Dec 5]. https:\/\/gskpro.com\/content\/dam\/global\/hcpportal\/en_SG\/products\/PDF\/Fluarix-tetra\/fluarix_tetra_pi_ipi10a_si_nh_approved_24jul19.pdf."}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2569735","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2025.2569735","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2569735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:40:33Z","timestamp":1786034433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2025.2569735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/21645515.2025.2569735"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2025.2569735","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2569735"}}